Food and Drug Administration (FDA) has received reports of people experiencing stomach paralysis after taking certain GLP-1 Receptor Agonist (RA) drugs, like Ozempic, Wegovy, and Rybelsus
The SARS-CoV-2 RNA interactome
Future research should aim to harmonize differentiation protocols, stem cell sources, and treatment concentrations to better define the therapeutic window and mechanisms of GLP-1-RA in regenerative applications
Unused Wegovy pens may be kept at room temperature (46F to 86F or 8C to 30C) for up to 28 days before use
Dosing protocols Phase 2 clinical trials used a titration schedule starting at 0.5mg weekly, escalating through 1mg, 2mg, 4mg, 8mg, and reaching maintenance doses of up to 12mg weekly over several months